The pre-filled saline syringes market size is projected to reach US$ 1,098.4 million by 2031 from US$ 554.9 million in 2023. The market is expected to register a CAGR of 8.9% during 2023–2031. An increasing product development and continuous innovation in pre-filled saline syringes are likely to remain key trends in the market.
The powerful features and benefits of pre-filled saline syringes drives the consumption and thus the market growth. These syringes not only ensure easy drug delivery but also reduce the risk of unsafe administration. The low risk and liability of pre-filled saline syringes is expected to further drive the market growth. With an increase in the number of geriatric populations the prevalence of chronic diseases has increased. Therefore, the demand for pre-filled saline syringes products is expected to increase in the forecast period. However, the increasing safety concerns and frequent product recalls of pre-filled saline syringes could hamper the pre-filled saline syringes market.
Pre-filled saline syringes are widely used in hospitals, nursing homes, and some types of pre-filled saline syringes can be used at home too. Pre-filled saline syringes are used to clean out an intravenous (IV) catheter, to prevent blockage and remove any medicine left in the catheter area after an IV infusion. Prefilled saline syringes, are available in different sizes, helps in improving clinician efficiency and workflow by reducing the time required for manual preparation. The most significant advantage of a prefilled saline syringe is that it reduces the likelihood of the solution coming into contact or entering the non-sterile parts of the syringe and thus helps in preventing contamination.
Hospital-acquired infections (HAIs) impacts the patients during stay and post discharge from the hospitals. According to the World Health Organization (WHO), hundreds of millions of patients are affected by HAIs yearly, leading to significant morbidity and mortality around the world. Moreover, in high-income countries, approximately 30% of patients in intensive care units (ICUs) are affected by at least one HAIs. This rate of HAIs is about 2-3 folds higher in the low and middle-income countries. Pre-filled saline syringes are designed to reduce hospital-acquired infections, reduce the risk of medication errors, and lower the risk of catheter damage. As per the Centers for Disease Control and Prevention (CDC), central line-associated bloodstream infections are among the four primary HAIs related to pediatric intensive care units. It is very important to flush vascular access devices before each infusion for assessing catheter function and preventing catheter-related complications. Pre-filled saline syringes can minimize the incidence of central line-related bloodstream infections, thereby improving the quality of care by saving additional time in the pediatric intensive care unit. Thus, the increasing prevalence of HAIs is expected to create a demand for disposable medical products such as pre-filled saline syringes, promoting market growth across the world.
Most of the global players pay attention toward the emerging market such as the Asia Pacific because of increasing prevalence of chronic diseases such as cancer and rising medical tourism. For instance, in India, the hospital networks have grown rapidly in the past few decades. Further, many Asian countries such as India, South Korea, Singapore, and Thailand are becoming the center of attraction for medical tourists. In addition, the government authorities of the countries in the European region are also focusing toward strengthening their medical tourism sector, resulting in boosting the flow of revenue. For instance, Poland and Spain have slowly grown as a favourite medical tourism destination in Europe. Therefore, the growing medical tourism in the developing and developed countries provide opportunity for pre-filled saline syringes market in order to provide world-class healthcare services by reducing the risk of medication errors, minimizing HAIs, and lowering the risk of catheter damage during and after hospitalization.
Key segments that contributed to the derivation of the Pre-Filled Saline Syringes market analysis are type and end user.
The geographic scope of the Pre-Filled Saline Syringes market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America has dominated the pre-filled saline syringes market. Factors leading to the growth of the pre-filled saline syringes market in North America are increasing geriatric population, rising prevalence of cancer, favorable reimbursement for cancer care, increasing healthcare expenditure by government and private players. In North America, the US is the largest market for pre-filled saline syringes. Further, the technological advancements have enhanced the safe and effective application syringes. Moreover, the syringes have evolved as easy, convenient, painless, and cost-effective. However, the pre-filled saline syringes market in Asia Pacific region is likely to register highest CAGR during the forecast period.
The regional trends and factors influencing the Pre-Filled Saline Syringes Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Pre-Filled Saline Syringes Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 554.9 Million |
| Market Size by 2031 | US$ 1,098.4 Million |
| Global CAGR (2023 - 2031) | 8.9% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Pre-Filled Saline Syringes Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Pre-Filled Saline Syringes Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The pre-filled saline syringes market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the pre-filled saline syringes market are listed below:
The “Pre-Filled Saline Syringes Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
The North America region dominated the pre-filled saline syringes market in 2023.
An increasing incidence of chronic diseases and hospital-acquired infections and growing geriatric population highly prone to diseases and infection are the driving factors impacting the pre-filled saline syringes market.
Increasing product development and continuous innovations are likely to act as future trends for the pre-filled saline syringes market.
Cardinal Health and BD are the leading players operating in the pre-filled saline syringes market.
US$ 1,098.4 million would be the estimated value of the pre-filled saline syringes market by 2031.
8.9% is the CAGR of the pre-filled saline syringes market.